나스닥 이야기
Quickly browse recent reports in the selected category.
-
[Nasdaq Stories] From Silicon to Systems: Assessing Synopsys (SNPS) EDA Monopoly in AI Semiconductors Post-Ansys Acquisition
Synopsys completed its $35B Ansys deal, creating an end to end platform from chip logic to multi physics simulation. We analyze its expanded $31B TAM,...
-
[Nasdaq Story] Casgevy Crosses the Monetization Inflection Point: Vertex (VRTX) Gene-Editing Commercialization Timeline and Valuation Review
Vertex Pharmaceuticals' CRISPR therapy Casgevy has entered an active revenue ramp up phase, easing initial launch delay concerns. Strong CF cash flow ...
-
[Nasdaq Story] Apple (AAPL) iPhone 17 On-Device AI and the Fall Upgrade Cycle: Catalysts for a Supercycle and the Valuation Litmus Test
Apple AAPL faces an upgrade supercycle test powered by on device AI in the iPhone 17. With over 800M older iPhones lacking AI support, pent up demand ...
-
[Nasdaq Story] Tesla (TSLA) After Robotaxi: $25B Annual CapEx and the Break-Even Economics of FSD Subscriptions
Tesla pivots toward FSD subscriptions and Cybercab robotaxi revenue. With annual CapEx topping $25B, near term margins face pressure while high tech m...
-
[Nasdaq Insights] Snapdragon X Elite's AI PC Penetration and Earnings Impact: The Bright and Dark Sides of Qualcomm (QCOM)'s On-Device Ecosystem
Qualcomm's Snapdragon X Elite powered Copilot+ PCs opened the on device AI era, but initial global PC penetration sits around 1%. Still, double digit ...
-
[Nasdaq Story] The Correlation Between da Vinci 5 Global Rollout and Procedure Growth: Testing Intuitive Surgical's (ISRG) AI Healthcare Multiples
Intuitive Surgical's da Vinci 5 is expanding across Europe and Asia, strengthening recurring revenues amid high macro volatility, valuation adjustment...